|
HYDROXYUREA | |||
PRODUCT IDENTIFICATION |
|||
CAS NO. | 127-07-1 | ||
EINECS NO. | 204-821-7 | ||
FORMULA | HONHCONH2 | ||
MOL WT. | 76.06 | ||
H.S. CODE |
|||
TOXICITY |
Oral rat LD50: 5760 mg/kg | ||
SYNONYMS | Hydrea; Hydroxycarbamide; Hydroxycarbamine; 羟基脲; | ||
Hydura; Hydurea; N-Carbamoylhydroxylamine; N-Hydroxyurea; Oxyurea; N-(aminocarbonyl)hydroxylamine; 1-hydroxyurea; Hidroxicarbamida; | |||
PRICE |
|
||
CLASSIFICATION |
|||
PHYSICAL AND CHEMICAL PROPERTIES |
|||
PHYSICAL STATE | white to light yellow powder | ||
MELTING POINT | 135 - 140 C | ||
BOILING POINT | |||
SPECIFIC GRAVITY | |||
SOLUBILITY IN WATER | freely soluble (decomposes in the presence of moisture) | ||
pH | |||
VAPOR DENSITY | |||
AUTOIGNITION |
|
||
NFPA RATINGS |
|||
REFRACTIVE INDEX |
|||
FLASH POINT |
|
||
STABILITY |
Stable under ordinary conditions (hygroscopic) |
||
APPLICATIONS |
|||
Hydroxyurea is an antimetabolite to be used as an antineoplastic agent. It acts
as an inhibitor of ribonucleoside reductase, an enzyme involved in the
conversion of ribonucleotides to deoxyribonucleotides, an essential process in
DNA synthesis. Hydroxyurea is also used as an immunosuppressant by decreasing
the amount of intracellular deoxynucleotides, essential in viral replication. It
is believed that it inhibits human immunodeficiency virus 1 (HIV-1). It is used
to treat some types of leukaemia and carcinoma of the head and neck, ovary, and
cervix, malignant melanoma, and blood disease polycythemia vera. Antimetabolite is a chemical compound that closely resembles a metabolite in molecular structure, but can interfering with the normal reactions of the essential metabolite. It prevent the cell from the utilization of the genuine substance necessary to normal biochemical reactions. Chemically modified nucleotides substituted or attached by special chemical groups or elements are studied and used to inactivate the normal biological operation in the living organism and the function of important enzymes. Aminopterin (4-aminofolic acid) and methotrexate (mthylaminopterin) are antagonists of folic acid, and used in the treatment of some neoplastic diseases. Azathioprine and mercaptopurine are purine antagonists. 5-Fluorouracil and fluorodeoxyuridine are examples of pyrimidine antagonists; used as an antineoplastic and as a component of chemotherapy regimens. DNA synthesis inhibitors for antitumor effects include: |
|||
SALES SPECIFICATION | |||
APPEARANCE |
white to light yellow powder | ||
PURITY |
98.0% min |
||
MELTING POINT | 135 - 140 C | ||
TRANSPORTATION | |||
PACKING | |||
HAZARD CLASS | |||
UN NO. | 1851 | ||
OTHER INFORMATION | |||
Hazard Symbols: XN, Risk Phrases: 22/33/36/37/38, Safety Phrases: 24/25 |
|
|